Health
Spironolactone may be safe to treat female pattern hair loss in breast cancer survivors – News-Medical.Net
Spironolactone is not associated with increased risk of female breast cancer recurrence, according to research from the George Washington University Department of Dermatology.
Reviewed by Emily Henderson, B.Sc.Sep 9 2020
Spironolactone is not associated with increased risk of female breast cancer recurrence, according to research from the George Washington University (GW) Department of Dermatology. The study, published in the Journal of the American Academy of Dermatology, found that the drug may be safe for use in treating breast cancer survivors with female pattern hair loss.
Androgens contribute significantly to the pathogenesis of female patterned hair loss. The…
-
Business24 hours agoIs Warren Buffett’s Berkshire Hathaway the smartest investment you can make today?
-
Noosa News10 hours agoCommissioner thanks police officer who threw a speed radar at a car
-
General24 hours agoTaiwan’s President Lai Ching-te calls for peace and dialogue with China while also calling for defence boosts
-
Noosa News18 hours agoCountdown on for Noosa Eat & Drink Festival 2025